Advertisement
Screener

LENZ THERAPEUTICS, INC. (LENZ) Material Contracts

LENZ THERAPEUTICS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-11: Form 10-Q; Exhibit 10.1; Description Outside Director Compensation Policy.
  • 2026-03-24: Form 10-K; Exhibit 10.13; Description Outside Director Compensation Policy..
  • 2024-08-14: Form 10-Q; Exhibit 10.1; Description Stock Purchase Agreement by and between LENZ Therapeutics, Inc. and Ridgeback Capital Investment, L.P., dated July 14, 2024..
  • 2024-03-22: Form 8-K; Exhibit 10.21; Description Registration Rights Agreement, dated March 21, 2024, by and among LENZ Therapeutics, Inc. and certain parties thereto..
FiledFormExhibitDescription
2026-08-1110-Q10.1Outside Director Compensation Policy
2026-03-2410-K10.13Outside Director Compensation Policy.
2024-08-1410-Q10.1Stock Purchase Agreement by and between LENZ Therapeutics, Inc. and Ridgeback Capital Investment, L.P., dated July 14, 2024.
2024-03-228-K10.21Registration Rights Agreement, dated March 21, 2024, by and among LENZ Therapeutics, Inc. and certain parties thereto.
2024-03-228-K10.16Outside Director Compensation Policy.
2024-03-228-K10.14Employment Offer Letter between LENZ Therapeutics, Inc. and Dan Chevallard dated March 21, 2024.
2024-03-228-K10.13Employment Offer Letter between LENZ Therapeutics, Inc. and Shawn Olsson dated March 21, 2024.
2024-03-228-K10.12Employment Offer Letter between LENZ Therapeutics, Inc. and Marc Odrich dated March 21, 2024.
2024-03-228-K10.11Employment Offer Letter between LENZ Therapeutics, Inc. and Evert Schimmelpennink dated March 21, 2024.
2024-03-228-K10.102024 Employee Stock Purchase Plan.
2024-03-228-K10.92024 Equity Incentive Plan and related form agreements.
2024-03-228-K10.8Form of Lock-Up Agreement.
2024-03-228-K10.7Form of LENZ Therapeutics, Inc., Stockholder Support Agreement.
2024-03-228-K10.6Form of Graphite Bio, Inc., Stockholder Support Agreement.
2024-02-2710-K10.27Compensation Recovery Policy
2023-11-158-K10.4Subscription Agreement, dated as of November 14, 2023
2023-11-158-K10.3Form of Lock-Up Agreement
2023-11-158-K10.2Form of LENZ Support Agreement
2023-11-158-K10.1Form of Graphite Support Agreement
2023-11-1310-Q10.2Separation and Release Agreement, dated as of September 7, 2023, by and between the Registrant and Josh Lehrer.
2023-11-1310-Q10.1Employment offer letter, dated as of August 21, 2023, by and between the Registrant and Kimberlee C. Drapkin.
2023-10-308-K10.2First Amendment to Lease by and between Graphite Bio, Inc. and Bayside Area Development, LLC, dated October 26, 2023
2023-10-308-K10.1Sublease agreement by and between Graphite Bio, Inc. and Soleil Labs, LLC, dated October 26, 2023
2023-03-2010-K10.24Master Development and Manufacturing Services Agreement (for cell therapy services), by and between WuXi Advanced Therapies Inc. and Registrant, dated November 7, 2022.
2023-03-168-K10.1Form of Retention and Severance Agreement
2022-03-2110-K10.23Offer Letter, by and between the Registrant and Alethia Young, dated October 25, 2021.
2021-12-208-K10.6EX-10 LEASE AGREEMENT EXECUTED
2021-11-168-K10.1Sublease Agreement between the Registrant and Annexon, Inc. dated November 10, 2021

Similar stocks

Stock NameCountryMarket CapPE Ratio
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48